Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells
about
Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cellsStatin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP?Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatinPleiotropic effects of statinsThe influence of statins on the free intracellular calcium concentration in human umbilical vein endothelial cellsStatins in heart failure: do we need another trial?Statin therapy and autoimmune disease: from protein prenylation to immunomodulationHMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statinsPravastatin suppresses the interleukin-8 production induced by thrombin in human aortic endothelial cells cultured with high glucose by inhibiting the p44/42 mitogen activated protein kinaseStatin Use and Risk of Cirrhosis and Related Complications in Patients with Chronic Liver Diseases: a Systematic Review and Meta-analysis.Pulmonary hypertension and right heart dysfunction in chronic lung disease.Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats.Bioactive lipid mediators in polycystic kidney diseaseInfluence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study.Therapeutic interventions and oxidative stress in diabetesThe impact of simvastatin on pulmonary effectors of Pseudomonas aeruginosa infection.Coronary microvasculopathy in heart transplantation: Consequences and therapeutic implications.Non-lipid-related effects of statins.Targeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protectionEfficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials.Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhage.Effect of nuclear actin on endothelial nitric oxide synthase expressionCan the potential benefits of statins in general medical practice be extrapolated to liver transplantation?Netrin-1 induces angiogenesis via a DCC-dependent ERK1/2-eNOS feed-forward mechanismThe paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough.Pathophysiology, treatment, and animal and cellular models of human ischemic stroke.Pitavastatin: evidence for its place in treatment of hypercholesterolemia.Simvastatin stimulates production of the antiapoptotic protein Bcl-2 via endothelin-1 and NFATc3 in SH-SY5Y cells.Stabilization of atherosclerotic plaques: new mechanisms and clinical targets.The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome.Statin therapy blunts inflammatory activation and improves prognosis and left ventricular performance assessed by Tissue Doppler Imaging in subjects with chronic ischemic heart failure: results from the Daunia Heart Failure Registry.Improvement in endothelial dysfunction in patients with systemic lupus erythematosus with N-acetylcysteine and atorvastatinSmall G proteins as novel therapeutic targets in cardiovascular medicine.Beyond lipid-lowering: effects of statins on endothelial nitric oxide.Prospects of statins in Parkinson diseaseAntiatherogenic Potential of Nigella sativa Seeds and Oil in Diet-Induced Hypercholesterolemia in Rabbits.Atorvastatin inhibits inflammatory hypernociception.Neuroprotection mediated by changes in the endothelial actin cytoskeleton.Simvastatin-induced cardiac autonomic control improvement in fructose-fed female ratsPrevention of pulmonary hypoplasia and pulmonary vascular remodeling by antenatal simvastatin treatment in nitrofen-induced congenital diaphragmatic hernia
P2860
Q24533532-3BB9211B-62F6-4774-83A1-5BEC1732C9A3Q24602803-0913E15D-0BC8-4B9A-BCFE-E920AE66D4C0Q24646870-A3AFA1AF-295A-49B4-89B4-F36E4904ADE7Q24647863-2971335F-AFEC-4C3B-90D9-43DECCBAD0E7Q24803214-CF92267B-E9BA-4633-B090-F1A54BD8002AQ26998966-4D916179-E6DC-4562-8B6B-DB83C686BDE3Q28236647-D9D2C5F3-B62B-409F-95FA-4ACF3CAAD445Q28344912-1D89E5BB-862F-44DD-94B2-20C62669D9B5Q28362055-6EF7E27E-7062-4852-92A4-930FC56BBA18Q30234533-E8FDA214-4676-4015-85EF-6B5396270520Q30432299-70044B97-3791-4D52-8588-5CC483AB4B61Q33358995-B896F1DC-A243-46CE-8C98-E8D1CD1A0A25Q33653643-16F8CD3B-6A4D-445D-837E-BB954E3B3CA9Q33711829-80BF9EE3-7EDC-4BE6-AA29-B8377AB7E9FCQ33870395-81E81596-F90B-41CD-A8A9-C221FF707062Q33882748-FB4C0B8A-93AA-4820-9709-E61DB2524106Q33891755-2382CD9C-0FC9-4D82-9F59-140AE82FAA4CQ33924588-95431067-2D41-444B-BB9E-C001011A9788Q34088803-A20ACDB3-6173-473F-9536-D6F19D551DC1Q34236781-C9D0A1E2-B1BE-4BEC-BC1F-C194DB2C5EB7Q34271800-B8219F35-6CCA-4C07-9CA9-277B4AA4E66AQ34407389-7F882339-0897-41EE-8D4A-BFC97582BFB1Q34468860-2941B488-C9FA-4300-8DBB-053EDD450B86Q34513279-DB208674-260D-4B11-9037-61147B22F4A0Q34516431-C00834A3-8E92-446E-8434-DB22C0CF5F60Q34569654-F7FF6671-96D4-4932-BE65-2C442435FCAAQ34628242-65784C6D-7812-43A2-A7B2-1535AAF40484Q34787972-43791505-05D5-4C0C-BBD9-3DCE4BE539DBQ34986368-E162D9B3-F901-4AD0-BD65-7CA712858761Q35021842-9CD9A12D-E615-4C9B-89A2-C1D4DDBC921CQ35028959-6E0164D1-9381-4518-AE7D-32423B35E57EQ35040324-D947AC7A-ABC0-4BBF-8C8D-5F9D509FDC96Q35047323-3CBABD74-C0B5-43CE-B22E-2231A427358DQ35084723-E242A5FD-18DE-4B49-ABB9-04FA9A034FDCQ35094028-0B6002C3-D5C2-4CE6-B4AE-93E41C7C047DQ35105001-EFD6821B-BA87-4E80-A23B-78B76CEE614BQ35119935-150D9416-7F5D-4599-9A6A-DCFEA707A834Q35128290-E861C4C7-41AF-46B0-BA19-381C3F3E3BCBQ35232415-C0C0155B-825B-4056-988E-43A71F0C682BQ35275342-BA9E3288-25CA-41E9-9F0D-2207727F29BF
P2860
Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Effects of the 3-hydroxy-3-met ...... in vascular endothelial cells
@ast
Effects of the 3-hydroxy-3-met ...... in vascular endothelial cells
@en
Effects of the 3-hydroxy-3-met ...... in vascular endothelial cells
@nl
type
label
Effects of the 3-hydroxy-3-met ...... in vascular endothelial cells
@ast
Effects of the 3-hydroxy-3-met ...... in vascular endothelial cells
@en
Effects of the 3-hydroxy-3-met ...... in vascular endothelial cells
@nl
prefLabel
Effects of the 3-hydroxy-3-met ...... in vascular endothelial cells
@ast
Effects of the 3-hydroxy-3-met ...... in vascular endothelial cells
@en
Effects of the 3-hydroxy-3-met ...... in vascular endothelial cells
@nl
P2093
P2860
P3181
P356
P1476
Effects of the 3-hydroxy-3-met ...... in vascular endothelial cells
@en
P2093
D Pérez-Sala
G Hernández
J Navarro-Antolín
O Hernández-Perera
R Sánchez-Pascuala
P2860
P304
P3181
P356
10.1172/JCI1500
P407
P577
1998-06-15T00:00:00Z